Spelling suggestions: "subject:"bonemarrow"" "subject:"marrow""
51 |
Evaluation of the factors mediating the survival of primates receiving total body X-irradiation and bone marrow transplantationHall, Arthur Stuart. January 1966 (has links)
Thesis (M.S.)--University of Wisconsin--Madison, 1966. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
52 |
Development and characterization of a bone marrow stem cell niche model / Aufbau und Charakterisierung eines Knochenmark-Stammzellnischen-ModellsConfalonieri, Davide January 2018 (has links) (PDF)
Kritische Knochendefekte stellen heutzutage ein ungelöstes Problem in der klinischen Praxis dar, da die verfügbaren prothetischen Optionen oft die mechanische Anpassung an das Gewebe nicht gewährleisten oder zu wichtigen immunologischen und Implantat-bedingten Komplikationen führen.
In diesem Kontext ermöglichen Tissue Engineering-Ansätze neue Strategien, um in vitro Zell-Material Interaktionen zu untersuchen und so die Implantatmaterialien zu optimieren.
In dieser Arbeit habe ich Zell-Material Interaktionen eines neuen Kollagen-basierten Scaffolds untersucht, das langfristig als Trägerstruktur für eine zellbasierte Therapie für kritische Knochendefekte entwickelt werden soll. Im Rahmen der Dissertation konnte ich belegen, dass die Kollagen-basierten makroporöse Mikrocarrier für die Zellvermehrung humaner mesenchymaler Stammzellen (MSC) und deren osteogene Differenzierung unter GMP Bedingungen verwendet werden können. Außerdem habe ich die die Kokultur von hämatopoietischen Stammzellen des Knochenmarks und multiplen Myelomzellen funktionell charakterisiert. Ich konnte erstmals Kulturbedingungen etablieren, die die Langzeitkultur ohne die Verwendung von Zytokinen ermöglicht. Mittels dieser Kokultur konnte ich ein Knochenmarknischen-Modell etablieren und die Untersuchung der Expression von zentralen Signalkaskaden der Homöostase dieser Nische untersuchen. Ich konnte die Expression von zwei verschiedenen Isoformen von Osteopontin nachweisen, die in Tiermodellen nicht gefunden werden. Diese Isoformen des Osteopontins habe ich kloniert und die rekombinanten Isoformen exprimiert und ihre Rollen in der Homöostase der Knochenmarknische untersucht.
Critical size bone defects represent nowadays an unresolved problem in the clinical practice, where the available prosthetic options often lack adequate mechanical matching to the host tissue or lead to important immunological and implant-related complications.
In this context, Tissue Engineering approaches promise more effective strategies to study cell-material interactions in vitro and consequently optimize implant materials.
In this work, I investigated the cell-scaffold interactions of a new collagen-based scaffold for a putative cell-based therapy for critical size defects to be developed. In the context of this thesis, I could demonstrate that the collagen-based macroporous microcarriers could be employed for the expansion and osteogenic differentiation of human mesenchymal stromal cells (MSCs) under GMP-compliant conditions. Moreover, I functionally characterized the co-culture of bone marrow hematopoietic stem cells and multiple myeloma cells. I was for the first time able to establish culture conditions allowing their long-term culture in absence of externally supplemented cytokines. Using this co-culture, I was able to establish a bone marrow niche model to investigate the expression of key signaling pathways involved in the niche´s homeostasis. I was able to demonstrate the expression of two different isoforms of Osteopontin, that could not previously be detected in animal models. Finally, I cloned these Osteopontin isoforms, expressed recombinant versions of the isoforms, and investigated their roles in the homeostasis of the bone marrow niche. / Kritische Knochendefekte stellen heutzutage ein ungelöstes Problem in der klinischen Praxis dar, da die verfügbaren prothetischen Optionen oft die mechanische Anpassung an das Gewebe nicht gewährleisten oder zu wichtigen immunologischen und Implantat-bedingten Komplikationen führen.
In diesem Kontext ermöglichen Tissue Engineering-Ansätze neue Strategien, um in vitro Zell-Material Interaktionen zu untersuchen und so die Implantatmaterialien zu optimieren.
In dieser Arbeit habe ich Zell-Material Interaktionen eines neuen Kollagen-basierten Scaffolds untersucht, das langfristig als Trägerstruktur für eine zellbasierte Therapie für kritische Knochendefekte entwickelt werden soll. Im Rahmen der Dissertation konnte ich belegen, dass die Kollagen-basierten makroporöse Mikrocarrier für die Zellvermehrung humaner mesenchymaler Stammzellen (MSC) und deren osteogene Differenzierung unter GMP Bedingungen verwendet werden können. Außerdem habe ich die die Kokultur von hämatopoietischen Stammzellen des Knochenmarks und multiplen Myelomzellen funktionell charakterisiert. Ich konnte erstmals Kulturbedingungen etablieren, die die Langzeitkultur ohne die Verwendung von Zytokinen ermöglicht. Mittels dieser Kokultur konnte ich ein Knochenmarknischen-Modell etablieren und die Untersuchung der Expression von zentralen Signalkaskaden der Homöostase dieser Nische untersuchen. Ich konnte die Expression von zwei verschiedenen Isoformen von Osteopontin nachweisen, die in Tiermodellen nicht gefunden werden. Diese Isoformen des Osteopontins habe ich kloniert und die rekombinanten Isoformen
exprimiert und ihre Rollen in der Homöostase der Knochenmarknische untersucht.
|
53 |
The blood flow to bone marrow and other organs following varying periods of intermittent hypoxia in the rat /Arscott, Phyllis Margaret January 1963 (has links)
No description available.
|
54 |
Erythropoiesis in the bone marrow of the fetal rabbit : a morphological study /King, John Edward January 1965 (has links)
No description available.
|
55 |
Ultrastructural cytochemical studies of normal human blood and bone marrow cells /Clark, Michael Allen January 1971 (has links)
No description available.
|
56 |
ACUTE MYELOID LEUKEMIA AND THE BONE MARROW MICROENVIRONMENT / FRIENDS OR FOES? ACUTE MYELOID LEUKEMIA AND THE BONE MARROW MICROENVIRONMENTPrabagaran, Pradhariny 11 1900 (has links)
Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow, affecting 1,100 Canadians annually. Older patients make up 75% of cases yet have the lowest survival rates due to the lack of tolerable treatments. Recently, the combination of Venetoclax and Azacitidine (Ven/Aza) has shown great therapeutic promise, however, chemoresistance has become a growing concern. Current evidence points towards a chemoprotective role from the bone marrow (BM) microenvironment, specifically by BM-derived mesenchymal stromal cells (BMSCs) and adipocytes. AML cells can manipulate BMSCs and adipocytes to create a niche that supports its own growth and evades chemotherapy. However, the role of the microenvironment in Ven/Aza chemoresistance has yet to be studied. Our objective was to study the ability of the microenvironment cells to induce AML chemoresistance to Ven/Aza. We employed a 2-dimensional direct contact co-culture system between MOLM-13 AML cells and BMSCs or adipocytes in both the absence and presence of Ven/Aza to determine the effects on the AML cells. In the absence of Ven/Aza, adipocyte co-cultured AML cells showed a 47% reduction in proliferation, 10% reduction in viability, yet a 1.7-fold increase in Maximal respiration when compared to the monocultured cells. In the presence of Ven/Aza, adipocyte co-cultured AML cells showed a significant increase in both proliferation and viability. Preliminary work investigating the mechanism of action of this support points toward an anti-apoptotic mechanism mediated by the upregulation of MCL-1 upon co-culture with adipocytes. Combination of Venetoclax and Tapotoclax, an MCL-1 inhibitor, abrogated the chemoprotection provided by BMSCs and adipocytes. Overall, our data suggests a dual role of adipocytes, where their inhibition or support of AML is context dependent. Therapeutic targeting of mechanisms for adipocyte chemoprotection such as MCL-1 upregulation may re-sensitize AML cells to Ven/Aza, thereby improving patient outcomes. / Thesis / Master of Science (MSc) / Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow, affecting 1,100 Canadians annually. Older patients make up 75% of cases yet have the lowest survival rates due to the lack of tolerable treatments. A novel combination of Venetoclax and Azacitidine (Ven/Aza) has shown great therapeutic promise, however, chemoresistance remains an important concern. Previous studies have implicated fat cells, or adipocytes, in AML chemoresistance, however, their role in Ven/Aza treatment has yet to be studied. Here, we show that adipocytes reduce growth of AML cells, yet enhance their metabolism. In the presence of Ven/Aza, adipocytes induce chemoresistance. We show preliminary data that this chemoprotection may be mediated by the upregulation of mitochondrial MCL-1 protein as inhibition of this protein neutralized the protection. By understanding the relationship between adipocytes and AML chemoresistance, we can target this and re-sensitize AML to Ven/Aza, thereby improving older patient outcomes.
|
57 |
Complement Component C5 and Graft-Versus-Host-DiseaseTodorova, Ekaterina January 2019 (has links)
Graft versus Host Disease (GvHD) is one of the main complications patients face after receiving a bone marrow transplant. Between 40-60% of bone marrow transplant recipients develop GvHD, with consequent systemic inflammation/fibrosis, reduced quality of life, graft failure, and mortality. We have previously demonstrated that donor-derived C5 is involved in the initiation and propagation of GvHD. Current approaches to inhibition of C5 share a serious flaw of indiscriminately blocking production of a mediator that is crucial for host defense. Targeted therapies to block C5 in specific cells, or anatomical sites, are the only way in which to achieve therapeutic benefit without compromising host defenses. Three lentiCRISPR v2-dCas9 gene editing viral constructs were created to selectively cleave the complement C5 gene, at three different sites. Our objective was to knockout complement C5 function in infected donor BM cells in a GVHD mouse model. Each of the three lentiCRISPR plasmids was separately co-cultured with PMDG2 and PSPAX2, in human embryonic kidney (HEK) 293T cells. Resultant viral particles were able to transfer the Cas-9 endonuclease gene into donor BM cells in vitro with a transduction efficiency of 52%. Treated donor BM cells were then retro-orbital injected into irradiated recipient mice. Control mice were transplanted following the same protocol excluding the lentiCRISPR treatment of BM. The lentiCRISPR treatment group demonstrated significantly lower total airway resistance (p = 0.05) and higher lung compliance (p = 0.014) when compared to the control group. When compared to the saline treated group however the lentiCRISPR group showed significantly higher total airway resistance (p = 0.004) and significantly lower lung compliance (p = 0.014). These results taken together suggest a possible reduction in GvHD severity in mice that received the lentiCRISPR treatment. This study can serve as a starting point for the development of this novel treatment of GvHD. / Thesis / Master of Science (MSc)
|
58 |
Bone Marrow and Bone as a Source for Postmortem RNAvan Doorn, Nienke L., Wilson, Andrew S., Willerslev, E., Gilbert, M.T.P. 05 1900 (has links)
No / The susceptibility of RNA to enzymatic degradation has been considered as a tool to estimate time-since-death in forensic samples, and it has previously been demonstrated that the choice of tissue is an important factor. In this study we have extracted RNA from decaying bone and bone marrow under the hypothesis that the delayed onset of putrefaction may render them a useful source in this context. In a preliminary study, total RNA was extracted from bone and bone marrow that had been sampled from six skeletally mature rabbits at time points between zero and 31 days after death. The levels of three specific RNA transcripts could be quantified using real-time polymerase chain reaction. Bioanalyzer results show rRNA bands in bone marrow samples up to 21 days postmortem. We hereby propose bone marrow as a potential source for postmortem RNA in forensic studies.
|
59 |
A gross and microscopic study of the bone marrow of clinicallly accessible bones of the immature, the mature, and the aged catFrey, Martin Raymond. January 1961 (has links)
Call number: LD2668 .T4 1961 F75
|
60 |
Molecular approaches to fungal infections in immunocompromised patientsWilliamson, Emma Charlotte Mary January 2001 (has links)
No description available.
|
Page generated in 0.0245 seconds